The usefulness of combined measurements of squamous cell carcinoma antigens 1 and 2 in diagnosing atopic dermatitis

Annals of Clinical Biochemistry

Volumn 49, Issue 3, 2012, Pages 277-284

  Ohta, Shoichiro ^a   Shibata, Rumiko ^b   Nakao, Yoshifumi ^a   Azuma, Yoshinori ^c   Taniguchi, Kazuto ^a   Arima, Kazuhiko ^a   Suzuki, Shoichi ^a   Shiraishi, Hiroshi ^a   Iwasaka, Tsuyoshi ^a   Izuhara, Kenji ^a  

^a SAGA UNIVERSITY   (Japan)

^b FUKUOKA NATIONAL HOSPITAL   (Japan)

^c SHINO TEST CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SQUAMOUS CELL CARCINOMA ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN 1; SQUAMOUS CELL CARCINOMA ANTIGEN 2; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD ALLERGY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER;

ANIMALS; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; RATS; RATS, WISTAR; SENSITIVITY AND SPECIFICITY; SERPINS; SEVERITY OF ILLNESS INDEX; UTERINE CERVICAL NEOPLASMS;

EID: 84861521895     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2011.011065     Document Type: Article

References (33)

1. Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977;40:1621-8
2. Senekjian EK, Young JM, Weiser PA, Spencer CE, Magic SE, Herbst AL. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma. Am J Obstet Gynecol 1987;157:433-9
3. Duk JM, de Bruijn HW, Groenier KH, et al. Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations. Gynecol Oncol 1990;39:186-94
4. Bolli JA, Doering DL, Bosscher JR, et al. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1994;55:169-73
5. Lara PC, Cuyas JM. The role of squamous cell carcinoma antigen in the management of laryngeal and hypopharyngeal cancer. Cancer 1995;76:758-64
6. Snyderman CH, D'Amico F, Wagner R, Eibling DE. A reappraisal of the squamous cell carcinoma antigen as a tumor marker in head and neck cancer. Arch Otolaryngol Head Neck Surg 1995;121:1294-7
7. Hefler L, Obermair A, Tempfer C, et al. Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer. Int J Cancer 1999;84:299-303
8. Mino N, Iio A, Hamamoto K. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Cancer 1988;62:730-4
9. Izuhara K, Ohta S, Kanaji S, Shiraishi H, Arima K. Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family. Cell Mol Life Sci 2008;65:2541-3
10. Izuhara K, Arima K, Kanaji S, Ohta S, Kanaji T. IL-13: a promising therapeutic target for bronchial asthma. Curr Med Chem 2006;13:2291-8
11. Yuyama N, Davies DE, Akaiwa M, et al. Analysis of novel disease-related genes in bronchial asthma. Cytokine 2002;19:287
12. Nishi N, Miyazaki M, Tsuji K, et al. Squamous cell carcinoma-related antigen in children with acute asthma. Ann Allergy Asthma Immunol 2005;94:391-6
13. Mitsuishi K, Nakamura T, Sakata Y, et al. The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis. Clin Exp Allergy 2005;35:1327-33
14. Suzuki K, Inokuchi A, Miyazaki J, Kuratomi Y, Izuhara K. Relationship between squamous cell carcinoma antigen and the clinical severity of allergic rhinitis caused by Dermatophagoides farinae and Japanese cedar pollen. Ann Otol Rhinol Laryngol 2010;119:22-6
15. Sakata Y, Arima K, Takai T, et al. The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1. J Biol Chem 2004;279:5081-7
16. Masumoto K, Sakata Y, Arima K, Nakao I, Izuhara K. Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1. J Biol Chem 2003;278:45296-304
17. Sakata Y, Arima K, Takeshita K, et al. Characterization of novel squamous cell carcinoma antigen-related molecules in mice. Biochem Biophys Res Commun 2004;324:1340-5
18. Kanaji S, Tanaka Y, Sakata Y, et al. Squamous cell carcinoma antigen 1 is an inhibitor of parasite-derived cysteine proteases. FEBS Lett 2007;581:4260-4
19. Uehara M, Izukura R, Sawai T. Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 1990;15:264-6
20. Kagi MK, Joller-Jemelka H, Wuthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 1992;185:88-92
21. Park JH, Choi YL, Namkung JH, et al. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables. Br J Dermatol 2006;155:778-83
22. Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 2006;43:75-84
23. Kakinuma T, Nakamura K, Wakugawa M, et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-41
24. Ricci G, Dondi A, Patrizi A. Useful tools for the management of atopic dermatitis. Am J Clin Dermatol 2009;10:287-90
25. Hauk PJ. The role of food allergy in atopic dermatitis. Curr Allergy Asthma Rep 2008;8:188-94
26. Laske N, Niggemann B. Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol 2004;15:86-8
27. Stenman J, Hedstrom J, Grenman R, et al. Relative levels of SCCA2 and SCCA1 mRNA in primary tumors predicts recurrent disease in squamous cell cancer of the head and neck. Int J Cancer 2001;95:39-43
28. Hsu KF, Huang SC, Shiau AL, et al. Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer. Int J Gynecol Cancer 2007;17:174-81
29. Cataltepe S, Schick C, Luke CJ, et al. Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2. Clin Chim Acta 2000;295:107-12
30. Wenzel S, Wilbraham D, Fuller R, Getz EB, Longphre M. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 2007;370:1422-31
31. Corren J, Busse W, Meltzer EO, et al. A randomized, controlled, phase 2 study of AMG 317, an IL-4Ra antagonist, in patients with asthma. Am J Respir Crit Care Med 2010;181:788-96
32. Phillips KA, Van Bebber S, Issa AM. Diagnostics and biomarker development: priming the pipeline. Nat Rev Drug Discov 2006;5:463-9
33. Trusheim MR, Berndt ER, Douglas FL. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov 2007;6:287-93